Heghine Khachatryan on New Insights Into Bleeding Mechanisms in Acquired Hemophilia A
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, reposted from RPTH Journal on LinkedIn:
”New insights into bleeding mechanisms in acquired hemophilia A
A recent publication in Research and Practice in Thrombosis and Haemostasis (RPTH) highlights an often under-recognized contributor to bleeding severity in acquired hemophilia A (AHA): platelet function abnormalities.
The study demonstrates that beyond FVIII inhibitors, transient but clinically relevant platelet aggregation defects may be present during the acute phase of AHA and can improve in remission.
These findings help explain why bleeding severity does not always correlate with FVIII levels alone.
Why this matters clinically:
• Reinforces the concept that AHA is a multifactorial bleeding disorder
• Supports broader hemostatic assessment in complex bleeding cases
• Encourages individualized management beyond factor replacement
Congratulations to the authors for advancing our understanding of the interplay between coagulation and platelet function in rare bleeding disorders.”
Quoting RPTH Journal‘s post:
”Platelet dysfunction in acquired hemophilia A
Acquired hemophilia A (AHA) presents with a bleeding pattern distinct from inherited hemophilia, yet the contribution of platelet function abnormalities has remained poorly explored.
Bleeding patterns in AHA differ from inherited hemophilia and may involve platelet dysfunction
δ storage pool disease was identified in several patients with monoclonal gammopathy of undetermined significance
Acquired platelet abnormalities may contribute to bleeding severity in AHA
Read the full article here.”
Article: Platelet function abnormalities in acquired hemophilia A
Authors: Raffaella Rossio, Anna Lecchi, Silvia La Marca, Lidia Padovan, Roberta Gualtierotti, Cristina Novembrino, Chiara Suffritti, Sara Arcudi, Alessandro Ciavarella, Federico Boggio, Simona Maria Siboni, Flora Peyvandi

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026
-
Jun 14, 2026, 19:38Jecko Thachil: Can We Predict and Prevent Bleeding in APL?
-
Jun 14, 2026, 19:32Highlights from Day 1 at the EHC Leadership Conference 2026
-
Jun 14, 2026, 18:01Ahmar U. Zaidi: The First Pivotal Study of a New Mechanism in Sickle Cell Disease
-
Jun 14, 2026, 18:00Lennart Lenk: Witnessing Former Boss Deliver a Plenary Talk at EHA 2026
-
Jun 14, 2026, 18:00Priya Sriskandarajah: Great Presentations on Recent Advances in Myelofibrosis at EHA 2026